<h4>Background</h4>Hormone receptor-positive, human epidermal growth factor 2-negative advanced breast cancer patients have had a wide range of therapeutical options since the incorporation of targeted therapies alongside classic chemotherapy. Here, NR4A1 is linked to breast carcinoma.